Risk factors for treatment denial and loss to follow‐up in an antiretroviral treatment cohort in Kenya
- 27 March 2007
- journal article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 12 (5) , 687-694
- https://doi.org/10.1111/j.1365-3156.2007.01830.x
Abstract
To evaluate risk factors for treatment denial and loss to follow-up in an antiretroviral treatment (ART) cohort in a rural African setting in western Kenya. Sociodemographic and clinical data of patients enrolled in an ART cohort were collected within 18 months of an observational longitudinal study and analysed by logistic and Cox regression models. Of 159 patients with treatment indication 35 (22%) never started ART. Pregnancy [adjusted odds ratio (AOR) 3.60, 95% confidence interval (CI) 1.10-11.8; P = 0.035] and lower level of education (AOR 3.80, 95% CI 1.14-12.7; P = 0.03) were independently associated with treatment denial. The incidence of total loss of patients under therapy was 43.2 per 100 person years (pys) (mortality rate 19.2 per 100 pys plus drop out rate 24 per 100 pys). Older age [adjusted hazard ratio (AHR) 1.06, 95% CI 1.01-1.12; P = 0.04], AIDS before starting treatment (AHR 5.83, 95% CI 1.15-29.5; P = 0.03) and incomplete adherence to treatment (AHR 1.05, 95% CI 1.03-1.07; P < 0.001) were independent risk factors for death. Incomplete adherence also independently predicted drop out because of other reasons (AHR 1.06, 95% CI 1.04-1.09; P < 0.001). Pregnancy and lower level of education, higher age, advanced AIDS stage and impaired compliance to ART were identified as risk factors for treatment denial and death, respectively. Adequate counselling strategies for patients with these characteristics could help to improve adherence and outcome of treatment programmes in resource-limited settings.Keywords
This publication has 25 references indexed in Scilit:
- Lessons Learned from Use of Highly Active Antiretroviral Therapy in AfricaClinical Infectious Diseases, 2005
- Efficacy of Antiretroviral Therapy Programs in Resource‐Poor Settings: A Meta‐analysis of the Published LiteratureClinical Infectious Diseases, 2005
- Long-Term Experience Providing Antiretroviral Drugs in a Fee-for-Service HIV Clinic in UgandaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIVAIDS, 2004
- Acceptability and uptake of a package to prevent mother-to-child transmission using rapid HIV testing in Abidjan, Côte d'IvoireAIDS, 2004
- Adherence to HAART and its principal determinants in a cohort of Senegalese adultsAIDS, 2003
- Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte dʼIvoireAIDS, 2003
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesThe Lancet, 2002
- Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-upAIDS, 2002
- Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002